Previous studies in our laboratories demonstrated that overexpression of manganese superoxide dismutase (MnSOD) suppressed both the incidence and multiplicity of papillomas in a DMBA/TPA multi-stage skin carcinogenesis model. The activity of activator protein-1 (AP-1), which is associated with tumor promotion, was reduced in MnSOD transgenic mice overexpressing MnSOD in the skin, suggesting that MnSOD may reduce tumor incidence by suppressing AP-1 activation. In the present study, we report that reduction of MnSOD by heterozygous knockout of the MnSOD gene (Sod2 7/+, MnSOD KO) increased the levels of oxidative damage proteins and the activity of AP-1 following TPA treatment. RNA levels of ornithine decarboxylase (ODC) were also increased, suggesting an increase in cell proliferation in the KO mice. Histological examination con®rmed that the number of proliferating cells in DMBA/TPA-treated mouse skin were higher in the KO mice. Interestingly, histological examination also demonstrated greater numbers of apoptotic cells in the KO mice after DMBA/TPA treatment. Evidence of apoptosis, including DNA fragmentation, cytochrome c release from mitochondria, and caspase 3 activation were also observed by biochemical assays of the skin tissues. Apoptosis was associated with an increase in nuclear levels of p53 as determined by Western analysis. Quantitative immunogold ultrastructural analysis con®rmed that p53 immunoreactive protein levels were increased to a greater level in the nuclei of epidermal cells from MnSOD KO mice compared to epidermal nuclei from wild type mice similarly treated. Moreover, p53 levels further increased in the mitochondria of DMBA/TPA treated mice, and this increase was much greater in the MnSOD KO than in the wild type mice, suggesting a link between MnSOD de®ciency and mitochondrial-mediated apoptosis. Pathological examination reveals no dierence in the incidence and frequency of papillomas comparing the KO mice and their wild type littermates. Taken together, these results suggest that: (1) MnSOD de®ciency enhanced TPAinduced oxidative stress and AP-1 and p53 levels, consistent with the increase in both proliferation and apoptosis events in the MnSOD KO mice, and (2) increased apoptosis may negate increased proliferation in the MnSOD de®cient mice during an early stage of tumor development.
Previous studies in our laboratories demonstrated that overexpression of manganese superoxide dismutase (MnSOD) suppressed both the incidence and multiplicity of papillomas in a DMBA/TPA multi-stage skin carcinogenesis model. The activity of activator protein-1 (AP-1), which is associated with tumor promotion, was reduced in MnSOD transgenic mice overexpressing MnSOD in the skin, suggesting that MnSOD may reduce tumor incidence by suppressing AP-1 activation. In the present study, we report that reduction of MnSOD by heterozygous knockout of the MnSOD gene (Sod2 7/+, MnSOD KO) increased the levels of oxidative damage proteins and the activity of AP-1 following TPA treatment. RNA levels of ornithine decarboxylase (ODC) were also increased, suggesting an increase in cell proliferation in the KO mice. Histological examination con®rmed that the number of proliferating cells in DMBA/TPA-treated mouse skin were higher in the KO mice. Interestingly, histological examination also demonstrated greater numbers of apoptotic cells in the KO mice after DMBA/TPA treatment. Evidence of apoptosis, including DNA fragmentation, cytochrome c release from mitochondria, and caspase 3 activation were also observed by biochemical assays of the skin tissues. Apoptosis was associated with an increase in nuclear levels of p53 as determined by Western analysis. Quantitative immunogold ultrastructural analysis con®rmed that p53 immunoreactive protein levels were increased to a greater level in the nuclei of epidermal cells from MnSOD KO mice compared to epidermal nuclei from wild type mice similarly treated. Moreover, p53 levels further increased in the mitochondria of DMBA/TPA treated mice, and this increase was much greater in the MnSOD KO than in the wild type mice, suggesting a link between MnSOD de®ciency and mitochondrial-mediated apoptosis. Pathological examination reveals no dierence in the incidence and frequency of papillomas comparing the KO mice and
Introduction
Manganese superoxide dismutase (MnSOD) is a nuclear-encoded primary antioxidant enzyme localized in mitochondria (Weisiger and Fridovich, 1973) . It has been demonstrated that MnSOD may act as a tumor suppressor and redox modulator. Increased expression of MnSOD has been shown to suppress the cancer phenotype in a large number of mammalian tumor cells, including human melanoma cells (Church et al., 1993) , mouse ®brosarcoma cells (Saord et al., 1994) , human breast cancer cells (Li et al., 1995) , SV-40 transformed human lung ®broblast cells (Yan et al., 1996) , human oral carcinoma cells , hamster cheek pouch carcinoma cells (Lam et al., 1999) , mouse JB6 epithelial cells (Amstad et al., 1997) , human glioma cells (Zhong et al., 1997) , and human prostate cancer cells . To determine whether and how expression of MnSOD may suppress the development of cancer in situ, we employed a well established skin carcinogenesis model consisting of sequential application of a sub-threshold dose of a mutagenic chemical initiator such as 7,12-dimethylbenz(a)-anthracene (DMBa), followed by repetitive treatment with a tumor promoter such as 12-Otetradecanoylphorbol-13-acetate (TPA). In this protocol, initiation is considered to result in a population of mutated cells which remain dormant until treatment with the promoter stimulates clonal expansion, which, in turn, leads to the formation of benign welldierentiated papillomas. A portion of these papillomas will progress to squamous carcinomas and eventually invasive cancer. Benign papillomas appear from 7 to 54 weeks after repetitive application of tumor promoter, depending on mouse strain tested, and the early stage of promotion is a reversible phenomenon (Agarwal et al., 1993) .
It is now well established that promotion with TPA produces oxidants and results in oxidative damage to macromolecules (Bowden et al., 1995) . The activity of xanthine oxidase, an enzyme capable of generating superoxide radicals, has been shown to be increased in mice treated with TPA Pence and Reiners, 1987) . The activity of antioxidant enzymes, such as SOD and catalase, is decreased in mouse skin treated with TPA (Reiners et al., 1991) . These results indicate that application of TPA to mouse skin leads to an increase in cellular pro-oxidants and a decrease in antioxidant capability, resulting in increased levels of oxidatively damaged products.
Reactive oxygen species (ROS) have been implicated as second messengers in regulating gene expression. It has been shown that oxidative stress can modulate the activity of protein kinases, which, in turn, phosphorylate a wide range of cellular proteins, including several redox sensitive oncogene and tumor suppressor gene products (Gopalakrishna and Andersen 1989). The structure of this group of proteins contains a tandem repeat of cysteine-rich amino acids in their regulatory domain (Nishizuka, 1988) . These amino acids are the target for oxidation. Activation of protein kinase activity has been widely demonstrated in mouse skin promoted with TPA (McSwine-Kennick et al., 1991; Verma et al., 1986; Fischer et al., 1989) . Since the activities of activator protein 1 (AP-1) components are generally modulated by phosphorylation (Karin, 1995) , the tumor promoter activity of TPA may, in part be due to its ability to generate mild oxidative stress resulting in activation of protein kinases with subsequent increased phosphorylation of AP-1 proteins.
Among tumor suppressor genes that may be regulated by TPA-induced oxidative stress, p53 is a prominent candidate. p53 is a homotetrameric transcription factor induced by DNA damaging-and oxidative stress-inducing agents. Several lines of evidence have linked p53-induced apoptosis to both oxidative stress and mitochondria. First, p53-mediated apoptosis was preceded by activation of various oxidoreductases and ROS generation prior to mitochondrial changes (Polyak et al., 1997) . Second, p53 activates the transcription of several mitochondrial pro-apoptotic proteins including Bax, a pro-apoptosis member of the Bcl-2 family (Miyashita and Reed, 1995) , Noxa, a BH3-only member of the Bcl-2 family (Oda et al., 2000) , and p53IAP1, p53-regulated apoptosis inducing protein 1 (Oda et al., 2000) . Third, a fraction of p53 is localized to mitochondria at the onset of p53-dependent apoptosis preceding changes in mitochondrial membrane potential, cytochrome c release, and caspase activation Marchenko et al., 2000) . Fourth, p53 localization to mitochondria has direct eects on mitochondrial function and biogenesis (Donahue et al., 2001) .
Our previous study using MnSOD transgenic mice overexpresssing MnSOD in the skin showed that 78% of non-transgenic female mice developed papillomas, averaging 2.1 papillomas per mouse, while 50% of MnSOD overexpressing mice developed papillomas, averaging 0.75 papillomas per mouse after 14 weeks of TPA treatment following a single application of DMBA (Zhao et al., 2001a) . Our results suggested that MnSOD may modulate cell signaling by activation of AP-1, resulting in reduction of tumors in MnSOD overexpressing mice.
To further elucidate the mechanisms by which MnSOD functions to suppress cancer, we use a wellcharacterized MnSOD heterozygous knockout mouse model (Sod2 7/+, referred to as MnSOD KO) and the multistage skin carcinogenesis model. The eect of MnSOD de®ciency on oxidative damage, levels of AP-1 and p53, frequency of cell proliferation and apoptosis, and tumor incidence were examined.
Results

DMBA/TPA treatment induced oxidative stress
It is well recognized that DMBA or TPA treatment can induce oxidative stress (Nakamura et al., 1999; Khajuria et al., 1998) . We have previously demonstrated that TPA application induced rapid oxidative stress at the subcellular level as indicated by increased 4-HNE modi®ed protein levels in both mitochondria and nuclei in a B6C3 carcinogenesis mouse model (Zhao et al., 2001b) . Another standard biomarker of oxidative damage is the formation of carbonyl groups (aldehydes and ketones), which are formed in the amino side chains of proteins (Stadtman, 1992) . To verify the presence of oxidative stress in the present model, carbonyls were detected by Western analysis. As shown in Figure 1 , the levels of oxidatively modi®ed proteins were increased by 6 h post TPA treatment, and the levels were higher in the KO mice. These results con®rmed that oxidative stress occurred early in mouse skin after TPA treatment.
MnSOD deficiency enhanced TPA-induced AP-1 activation
TPA has been demonstrated to cause an induction of AP-1 activity in the skin, which activates expression of several genes required for cell proliferation (Bowden et al., 1995) . The results from quanti®cation of AP-1 activity by electrophoretic mobility shift assay (EMSA) showed that AP-1 binding activity in both the WT and KO mice was signi®cantly increased within 24 h post TPA treatment following a single dose of DMBA application (Figure 2 ). The KO mice had relatively higher AP-1 binding activity compared to wild type littermates similarly treated. DMBA alone has no signi®cant eect on the increase of AP-1 binding activity in either strain (Figure 2) .
Since the AP-1 complex may consist of homo-or heterodimers of various Fos, Jun and Fra family members, supershift assays were performed by preincubating samples used in the EMSA reaction with antibodies against members of the AP-1 family. Figure  3 showed that an antibody against Jun D clearly shifted the AP-1 complex; less prominent shifted bands were seen with anti-Jun B and anti-c-Jun antibodies. There was no shift with antibodies to c-Fos and Fra-1.
Western analysis (Figure 4 ) further demonstrated that Jun D was increased in the skin within 24 h after TPA treatment. The presence of other Jun family members was undetectable by Western analysis in the same set of samples used for Jun D analysis (data not shown). These results are complementary to those previously reported in a MnSOD overexpressing mouse model (Zhao et al., 2001) , and suggest that MnSOD levels regulate AP-1 activity, at least in the early stages after TPA treatment.
To determine whether increased AP-1 activation is associated with an increase in proliferation, epithelial cell mRNA levels of ODC, which is required for clonal expansion of epidermal tumor cells in vivo, were examined. The mRNA levels of ODC were signi®cantly increased within 24 h after TPA application in both WT and KO mouse skin, and KO mouse skin had higher ODC mRNA levels than WT mouse skin ( Figure 5 ).
MnSOD deficiency enhanced TPA-induced cell proliferation
To directly analyse cell proliferation, histological examination was performed to identify mitotic cells in the basal layer of the epidermis. Ten slides from each group were examined by counting mitotic cells per 300 cells for each slide, and the results are shown in Table 1 . The results indicated that the numbers of proliferating cells were increased in DMBA/TPAtreated mouse skin, and proliferating cells were higher in the KO mice.
Apoptosis is a prominent process following carcinogen treatment
Histological examination of mouse tissues treated with DMBA/TPA also showed frequent apoptosis and adjacent single cell mitosis (®gure not shown). Apoptotic and mitotic cells were found almost exclusively in the basal layer of the epidermis. The numbers of apoptotic and mitotic cells were tabulated in Table 1 . There were increases in the number of apoptotic and mitotic cells in epidermal cells from both KO and WT mice treated with DMBA when compared with vehicle-treated control groups (DMSO alone). The number of apoptotic and mitotic cells in epidermal cells from KO mice and WT mice treated with DMBA plus TPA were signi®cantly increased (approximately 10-fold) in comparison with vehicle treated control groups (DMSO alone). In addition, epidermal cells of KO mice treated with DMBA/TPA had signi®cantly more apoptotic and mitotic cells (approximately twofold) than WT mice similarly treated.
DNA fragmentation can be detected within 24 h in KO mouse skin post TPA treatment. As shown in Figure 6 , DNA fragmentation occurred within 24 h after TPA application, which was clearly detectable in the DNA sample from KO mouse skin.
To document further apoptosis in skin samples, levels of cytochrome c immunoreactive protein and caspase activity were assayed. Western analysis indicated increasing levels of cytochrome c with time in the mitochondrial supernatant fraction after TPA treatment, with a peak at 6 h ( Figure 7a ). DMBA treatment alone did not produce a signi®cant increase of caspase-3 activity (Figure 7b ). Treatment with DMBA followed by TPA resulted in an increase in caspase-3 activity that was detectable by 6 h and became signi®cant at 24 h post TPA application in the KO mice.
To determine whether the p53 levels were correlated with the observed increase in apoptosis, Western analysis was performed to detect changes in p53 protein levels after carcinogen treatment. Figure 7c showed that protein levels of p53 in the nucleus were increased with time in both WT and KO mice relative to the controls. The increase was highest at 6 h post TPA in the KO mice.
To verify the location of p53 in situ, immunogold electron microscopy was performed in epidermal cells after carcinogen treatment. Epidermal cells stained with normal rabbit serum did not show labeling. Immunoreactive p53 was observed in cytoplasm, nucleus and mitochondria. Interestingly, p53 levels were highest in mitochondria of DMBA/TPA treated cells (Figure 8 ). For quantitative comparison, 30 epidermal cells from each mouse were photographed at the same magni®cation. As shown in Table 2 , weak labeling was present in mitochondria, nucleus and cytoplasm in both WT and KO mice treated with either DMSO or DMBA. In epidermal cells of KO mice treated with DMBA and TPA, labeling was Thirty micrograms of total nuclear protein was loaded in each lane. Ponceau staining of the membrane was used to verify similar amounts of total protein loaded and to monitor the uniformity of the transfer Figure 5 Quantitative RT ± PCR analysis of ODC mRNA. The relative densities of the mRNAs were quanti®ed using results from three sets of independent experiments. **Signi®cant dierence from the control (WT or KO) group, P50.01; ## Signi®cant dierence from the TPA 24 h WT group, P50.01 
Pathological analysis revealed similar incidence of papillomas
Since both proliferation and apoptosis were increased to a greater extent in the MnSOD KO compared to the wild type littermates similarly treated, we compared the tumor incidence in these animals to determine the overall eect of the observed increased cell turnover. Following 28 weeks of application of TPA after a single dose of DMBA, no papillomas were identi®ed in WT and KO mice treated with vehicle alone (Table 3) . Seventy-eight per cent of the treated WT and 70% of treated KO female mice developed papillomas. In total, there were 15 papillomas in the WT and 16 papillomas in the KO female mice, resulting in less than two papillomas/mouse. No carcinomas were identi®ed in any animals.
Discussion
Numerous studies in cultured cells suggested that MnSOD, a primary antioxidant enzyme, might function as a new type of tumor suppressor gene (Church et al., 1993; Saord et al., 1994; Urano et al., 1995; Li et al., 1995 Li et al., , 1998 Yan et al., 1996; Liu et al., 1997; Lam et al., 1997; Amstad et al., 1997; Zhong et al., 1997) . We have previously studied the potential tumor-suppressor function of MnSOD in vivo by using a two-stage carcinogenesis model (Zhao et al., 2001b) . Results from our previous study demonstrated that overexpression of MnSOD reduced tumor incidence, levels of oxidative stress, and activities of AP-1. The results from the present studies using MnSOD de®cient mice con®rmed and extend our previous ®nding on the role of MnSOD in suppressing AP-1 activity and provided important insights into the delicate relationship between the role of MnSOD in proliferation and apoptosis in an early stage of cancer development. Our results demonstrate that although cell turnover is drastically altered in MnSOD KO mice following DMBA/TPA treatment, resultant tumor formation is not altered, documenting a tight regulation of apoptosis and proliferation in the mouse skin. Examination of early biochemical and molecular events in tumor promotion suggested that MnSOD de®ciency leads to an increase in epithelial cell AP-1 activity and levels of ODC mRNA, a cell proliferation gene that is an essential eector of TPA-induced promotion of mouse skin tumors. Furthermore, the number of dividing cells was increased to a greater extent in the MnSOD KO mouse skin in comparison with wild type mouse skin after DMBA/TPA treatment. These ®ndings are consistent with results from previous studies of TPA-induced cellular transformation using a well characterized mouse skin epithelial cell (JB 6) model (Bernstein et al., 1991) .
An important observation from histological examination is that both cell proliferation and apoptosis in DMBA/TPA-treated mouse skin were higher in KO mice, documenting that epithelial cell turnover was higher following chemical treatment in the KO mice. The increase in apoptotic cells was consistent with the increase in several biochemical markers including DNA fragmentation, cytochrome c release, and caspase activation in the MnSOD KO mice. To our knowledge, this is the ®rst study which demonstrates the role of MnSOD in apoptosis during tumor promotion. Previous work from this and other laboratories have demonstrated that increased expression of MnSOD protects against numerous agents and conditions that cause oxidative stress and/or cell death. Transfection of the MnSOD gene into cultured cervical carcinoma cells prevents cell death resulting from treatment with tumor necrosis factor (Wong et al., 1989) . Expression of the MnSOD gene by transfection with the human MnSOD cDNA results in cells that are resistant to paraquatinduced cytotoxicity in a mouse ®broblast cell line (C3H10T1/2) (St. Clair et al., 1991) . Stable expression of MnSOD in mouse ®brosarcoma cells protects against alkaline conditions (Majima et al., 1998) and chemical hypoxia-induced apoptosis (Kiningham et al., 1999) . Expression of MnSOD in insulinoma cells prevents IL-1beta-induced cytotoxicity and reduces nitric oxide production (Hohmeier et al., 1998) .
Overexpression of MnSOD in neuronal cells protects neurons from iron and peroxynitrite induced apoptosis (Keller et al., 1998) and NMDA mediated toxicity (Gonzalez-Zulueta et al., 1998) . Apoptosis caused by oxidized low-density lipoprotein has been shown to be MnSOD dependent (Kinscherf et al., 1998) . Plasmid/ liposome transfer of MnSOD transgene prevents ionizing radiation-induced apoptosis in human esophagus organ explant culture (Epperly et al., 2000) . These ®ndings point to the versatility of MnSOD in prevention of apoptosis against cytotoxic and therapeutic agents.
The fact that both proliferation and apoptosis were increased in the MnSOD de®cient mice may be due to its unique role in regulating ROS levels in mitochondria. It has been demonstrated that mitochondrial respiration can remove superoxide radicals generated outside mitochondria (Guidot et al., 1995) . We have shown that increased MnSOD in the mitochondria can prevent apoptosis initiated outside the mitochondria (Majima et al., 1998) . These results coupled to our results that overexpression of MnSOD in transgenic mouse model reduced 4-HNE modi®ed protein levels in both mitochondria and nuclei (unpublished observations) suggest that ROS may be an important link between mitochondria and the nucleus. The ®ndings that overexpression of MnSOD decreases p53-mediated apoptosis and that MnSOD overexpression decreases p53-gene expression at the promoter level (Drane et al., 2001) further strengthens the connection between MnSOD and nuclear events. It is possible that p53 and MnSOD genes are mutually regulated, leading to coordinated modulation of various cellular processes including apoptosis. It has been demonstrated that Figure 8 Representative Immunogold electron microscopy of epidermal cells with rabbit anti-p53 polyclonal antibody. Mice were treated with DMBA followed by TPA 2 weeks later. Twenty-four hours after TPA, the mice were sacri®ced and skin removed. The gold beads are localized primarily in the mitochondria of epidermal cells (216006). Labels: M. mitochondria. Arrows indicate immunogold staining in the mitochondria . Thus, it is not surprising that the incidence and frequency of papillomas in the MnSOD KO mice were not dierent from those in the wild type mice similarly treated. Our in vivo results demonstrated important roles of MnSOD in regulation of cell proliferation and cell death, which in turn impart subsequent tumor formation. It will be interesting to determine the time course of these events to identify the window of opportunity for antioxidant modulation of tumorigenesis. Although p53 has been called the guardian of the genome, activation of apoptosis is an important mechanism of p53 tumor suppression. Additional interesting observations from the present study is the ®nding that p53 levels are not only increased in the nucleus but are also signi®cantly increased in the mitochondria after DMBA/TPA treatment. These ®ndings suggest that p53 may induce apoptosis in vivo via both transcription-dependent and transcriptionindependent pathways. Apoptosis mediated by p53-dependent transcriptional activation of its target genes has been extensively studied (see, Tokino and Nakamura, 2000; Moll and Zaika, 2001; for reviews). p53-mediated transcriptional activation of proapoptotic mitochondrial proteins such as Noxa, AIP1 and Bax leading to mitochondrial dysfunction has been documented; however, the requirement of transcriptional activation of p53-target genes in apoptosis remains unclear. Our ®nding that the levels of p53 in nuclei of MnSOD KO mouse skin is higher than in nuclei of wild type mouse skin similarly treated is consistent with enhanced apoptosis via the p53 transcriptional dependent pathway. However, further studies using conditional inactivation of the p53 gene or its function at an early stage of cancer development will be needed to verify this possibility.
Our data also suggest that p53 translocation to mitochondria might be an additional mechanism by which DMBA/TPA-induced apoptosis, and suggest that this mechanism is enhanced in MnSOD de®cient mice. It has been shown that rapid translocation of p53 protein directly to mitochondria occurs in a broad spectrum of cell types, and translocation enhances the apoptotic potency of p53 (Moll and Zaika, 2001 ). The translocation of p53 to mitochondria following DMBA/TPA treatment precedes cytochrome c release and caspase 3 activation, ®ndings are consistent with those reported by Soengas et al. (1999) for cMycinduced apoptosis in mouse embryonic ®broblasts. Thus, p53 mitochondrial translocation may be a mechanism by which p53 can amplify the apoptosis signal in an early stage of cancer development.
Mitochondria are central integrators and transducers for pro-apoptotic signals, performing the integration between the non-speci®c inducer phase and the ®nal execution phase of apoptosis. A major reason for the central role of mitochondria is that these organelles store a host of critical apoptotic activators and eectors of cell death in their intermembranous space.
These include cytochrome c (Goldstein et al., 2000) , Smac/Diablo (a cytochrome c-dependent caspase coactivator) (Du et al., 2000; Verhagen et al., 2000) , AIF, a¯avoprotein that activates nuclear endonucleases (Susin et al., 1999) , and procaspases 2, 3 and 9 (Porter, 1999) . Our results demonstrating a signi®cant increase in cytosolic cytochrome c supports the role of mitochondria in tumor promoter-induced apoptosis in the MnSOD KO mice. Since p53 gene alterations were rare or absent in papillomas and are associated with late events of DMBA-TPA-induced carcinomas (Ruggeri and Klein-Szanto, 1995) , activation of wild type p53 instead of p53 mutation might be the cause of apoptosis in the early stage of skin carcinogenesis.
In summary, the data presented here suggest that DMBA/TPA treatment induced dual eects in the C57BL/6 mice model: an increase in cell proliferation via AP-1 mediated pathway and an increase in apoptosis through activation of tumor suppressor gene p53, both of which were enhanced in the MnSOD de®cient mice. The increase in these two opposing events may oset one another resulting in similar numbers of papillomas in the MnSOD KO mice and their wild type littermates. These results demonstrated the critical role of MnSOD in regulating tumorigenesis and suggest novel opportunities for antioxidant based intervention. Further studies to investigate a cause/ eect relationship between AP-1 and p53 activation and changes in cell proliferation/apoptosis is needed to con®rm this possibility.
Materials and methods
Mice
Heterozygous C57BL6 MnSOD knockout mice (sod2 7/+, KO) were generated using a standard gene targeting method as previously described (Remmen et al., 1999) . The C57BL/6 mice used for breeding were purchased from Harlan Sprague Dawley (Indianapolis, IN, USA) . Characterization of the MnSOD knockout mice has been previously reported (Remmen et al., 1999) . A 30 ± 80% decrease in MnSOD activity in all tissues of the heterozygous ospring (liver, kidney, lung, brain, heart, muscle, stomach, and spleen) has been documented, and there were no alterations in CuZnSOD, glutathione peroxidase, or catalase activities in any of these tissues. Thus, there was no up-regulation of the activities of other major antioxidant enzymes to compensate for the decrease in MnSOD activity. For all experiments in this study, female KO mice that exhibited approximately a 40% decrease of MnSOD activity in the skin cells (the activity was measured by using the method described by Spitz and Oberley (1989) ) and their female wild type littermates (sod2 +/+, WT) were used.
Two-stage carcinogenesis
Hair on the back of female mice 6 ± 8 weeks of age was shaved 2 days prior to application of vehicle or carcinogen. Mice in the resting stage of the hair cycle were chosen for subsequent treatment. A single dose of 20 nmol DMBA (Sigma, St. Louis, MO, USA) dissolved in dimethylsulfoxide (DMSO) was painted on each mouse. After 2 weeks, 4 mg of TPA, also dissolved in DMSO, was applied 5 days per week to the same area for 28 weeks. After euthanasia, skin from each mouse was removed and ®xed in 4% neutral buered formaldehyde for subsequent pathological examination. For the study of the early events of skin carcinogenesis by biochemical and molecular analyses, skin tissues were taken at indicated times after one application of DMBA followed 2 weeks later by a single application of TPA.
Experimental groups for studies of apoptosis and proliferation
Fourteen female mice (seven MnSOD WT and seven MnSOD KO) were studied. Mice were treated with either DMSO (control) (n=2 for each group), DMBA (n=2 for each group), or DMBA followed 2 weeks later with TPA (n=3 for each group).
Light and electron microscopic examination
Skin was isolated and ®xed 24 h after TPA treatment. For pathology examination, 24 female mice (11 MnSOD WT and 13 MnSOD KO), were studied. Mice were treated with either DMSO (control) (n=2 for WT, n=3 for KO group), or DMBA followed 2 weeks later with TPA for 28 weeks (n=9 for WT, n=10 for KO group). Skin tissues were ®xed in 4% formaldehyde in phosphate-buered saline (PBS) for 1 h. After rinsing with PBS, tissues were dehydrated with graded ethanol and embedded in paran. Paran sections were cut at 4 mm and mounted on glass slides. Tissue sections were analysed in a blinded fashion by a pathologist (TDO) to determine the number of papillomas.
For histological examination of apoptosis, the tissues were ®xed with Karnovsky's ®xative for 1 h at room temperature and then rinsed in 0.1 M Sorenson's phosphate buer pH 7.4 for 30 min. After post-®xation in Caul®eld's osmium tetroxide with sucrose for 30 min, the tissues were dehydrated in graded ethanols and embedded in epoxy resin. Thick sections of Epon-embedded skin tissues were mounted on glass slides and stained with toluidine blue. Apoptotic and mitotic cells were counted by light microscopy.
For electron microscopic examination, ultrathin sections were mounted on copper grids and counter-stained with uranyl acetate followed by lead citrate. Apoptotic and mitotic cells were examined by electron microscopy and photographed. The following ultrastructural features were used to identify apoptosis: cell shrinkage, chromatin condensation, and formation of cytoplasmic blebs and apoptotic bodies.
Immunogold labeling
Skin tissues were ®xed for 1 h in Carson Millonig's ®xative followed by rinsing with 0.1 M Sorenson's phosphate buer pH 7.4 for 30 min. Tissues were dehydrated in graded ethanol and embedded in LR White resin. LR white embedded tissue blocks were trimmed and sectioned. Thin sections were mounted on 1% collodion membrane-coated nickel grids. Sections were rinsed with TBS and treated with BSA-C blocking solution (Aurion, AA Wageningen, the Netherlands) for 30 min to block nonspeci®c staining and then washed with TBS for 5 min. The grids were incubated with primary antibody (rabbit anti-p53 polyclonal antibody diluted 1 : 40, Santa Cruz Biotechnology, Santa Cruz, CA, USA) at 48C overnight. After incubation, grids were rinsed in four changes of TBS washing buer for 5 min each and one change of alkaline TBS for 10 min. Grids were incubated with gold conjugated secondary antibody (15 nm gold conjugated goat anti-rabbit IgH+L, BB International, Cardi, UK) diluted at 1 : 75 was incubated for 90 min at room temperature. Grids were then rinsed in two changes of TBS wash buer for 10 min each, followed by washing with two changes of distilled water. The grids were counterstained with 2% uranyl acetate (for 10 min), and observed and photographed with an electron microscope (Hitachi H-600). All of the sections for quantitative immunogold EM analysis were stained simultaneously under the same conditions. As a control, normal rabbit serum was used in place of primary antibody.
Quantitative analysis of p53 immunoreactive protein
Micrographs were randomly taken at 10 0006magni®cation. Only the epidermal layer was analysed, and stratum corneum and the cells of the hair follicles were not analysed. The areas of mitochondria, cytoplasm and nucleus in selected epidermal cells and the density of p53 immunogold labeling were quantitatively analysed with image analysis software, Scion Image Beta 4.02 (Scion Corporation Frederick, MD, USA), running on a PC computer. (Dell OptiPlex GX200).
Preparation of nuclear extract from skin samples
Skin cells were stripped o using an autoclaved glass slide and suspended in 400 ml of buer A (10 mM HEPES-KOH with 1.5 mM MgCl 2 , 10 mM KCl, 0.2 mM phenylmethylsulfonyl¯uoride (PMSF), 5 mM of dithiothreitol (DTT), and protease inhibitors, 5 mg/ml of pepstatin, leupeptin and aprotinin). After gentle vortexing and centrifugation, the supernatant was transferred to a new tube. The pellet was resuspended in 400 ml of buer A and homogenized in a 10-ml Wheaton homogenizer (15 times up-and-down). The combined supernatant (about 800 ml) was kept on ice for 30 min. Twenty-®ve microliters of 10% NP-40 was then added and the sample was vortexed vigorously for 25 s. The lysate was centrifuged at 14 000 r.p.m. (or 17 500 g) for 1 min. The supernatant was collected and subsequently referred to as cytoplasmic fraction. The pellet was dissolved in 120 ml of buer B (20 mM HEPES-KOH with 1.5 mM MgCl 2 , 420 mM NaCl, 35% glycerol, 0.2 mM PMSF, 5 mM of DTT, 0.2 mM EDTA (pH 8.0)) containing the protease inhibitors, 5 mg/ml of pepstatin, leupeptin and aprotinin. The sample was kept on ice for 30 min, centrifuged at 12 000 r.p.m. for 5 min, and the supernatant, identi®ed as nuclear extract, was frozen at 7808C. The nuclear extract was used to measure AP-1 binding activity, levels of jun oncoproteins and p53 levels in the nucleus. Protein concentration was measured by a colorimetric assay (BioRad Laboratories, Richmond, CA, USA).
Isolation of mitochondrial supernatant from skin cells
Stripped skin cells were suspended in 1 ml mitochondria isolation buer (0.225 M mannitol, 0.075 M sucrose, 1 mM EGTA, pH adjusted to 7.4 with a few drops of 0.5 M Tris) in a 15-ml plastic tube and homogenized by using scale 2 of a Wheaton homogenizer for three times of 30-s strokes. The tissue was removed by centrifugation at 576 g (220 r.p.m.) for 5 min in a Sorval SS34 rotor. The supernatant was ®ltered through a nylon screen cloth (Small Parts Inc., Miami Lakes, FL, USA) and centrifuged at 9000 g (8700 r.p.m.) for 10 min. Supernatant was kept and designated as mitochondrial supernatant fraction. This fraction was used to measure cytochrome c release from mitochondria. The pellet was washed by adding 0.5 ml of mitochondria isolation buer and centrifuging at 9000 g for 5 min. This washing step was repeated one more time. The mitochondrial pellet was resuspended in 150 ml of mitochondria isolation buer containing 0.1% Trion X-100. This fraction was labeled the mitochondria fraction and kept at 7808C.
Preparation of cytosolic fraction
Skin cells were stripped and extracted by homogenization as described above except that 1 ml of homogenization buer (20 mM HEPES (pH 7.0), 5 mM EGTA, 10 mM 2-mercaptoethanol, 1 mM PMSF, 1 mg/ml leupeptin, 1 mg/ml aprotinin, 1 mg/ml pepstatin) was used instead of Buer A. The total cell lysate, cytosol and membrane fraction were prepared as previously described (Das et al., 1998) . Brie¯y, after homogenization, the lysate was centrifuged (50 g or 600 r.p.m., 5 min) to remove tissue debris. The resulting supernatant was designated total cell lysate, and 100 ml of it was kept at 7808C. The remainder of the total cell lysate was centrifuged at 10 000 g for 1 h at 48C. The supernatant was designated as cytosolic fraction and kept at 7808C, and was subsequently used to measure carbonyl proteins and caspase-3 activity.
DNA fragmentation
Skin cells were suspended in 1 ml cell lysis buer (50 mM Tris-HCl, pH 8.0 containing 20 mM EDTA, 0.5% SDS and 0.6% NaCl) containing 50 ml of proteinase K (10 mg/ml), and then incubated at 378C overnight. The subsequent steps have been described previously (Zhao et al., 2001a) . In brief, crude DNA preparations were extracted with phenol : chloroform : isoamyl alcohol (25 : 24 : 1) and precipitated with 0.1 volume of 3 M sodium acetate and 2.5 volumes of 100% ethanol. The collected DNA was dissolved in TE buer (10 mM) Tris, pH 8.0 with 1 mM EDTA). The same amount of DNA was resolved by electrophoresis on a 1.2% agarose gel and visualized by UV¯uorescence after staining with ethidium bromide.
Caspase-3-like cleavage activity assay
Measurement of caspase-3 activity of tissue has been previously reported (McGarrity et al., 2001) . Using equal protein concentrations of the cytosolic fraction and ApoAlert Caspase-3 Fluorescent Assay Kit (Clontech Laboratories, Palo Alto, CA, USA), the caspase-3 activity was analysed according to the protocol provided. Fluorescence was measured with a Spectra MAX GEMINI Reader (Molecular Devices, Sunnyvale, CA, USA).
Detection of oxidatively modified proteins
The OxyBlot protein oxidation detection kit (s7150, Intergen, Purchase, NY, USA) was used to perform the assay. The reaction procedures were performed according to the manufacturer's instructions. Ten per cent SDS ± PAGE gel was used for separation of the samples.
Electrophoretic mobility shift assays (EMSAs)
AP-1-DNA binding activity was analysed in nuclear extracts. The AP-1 double-strand oligonucleotide (5'-CGCTTGAT-GAGTCAGCCGGAA-3') was purchased from Promega (Madison, WI, USA). A 25-ml reaction solution contained 6 mg of nuclear extract, 5 ml of 56binding buer (50 mM TrisHCl, pH 7.4, with 20% glycerol, 5 mM MgCl 2 , 2.5 mM EDTA, 5 mM DTT and 0.25 mg/ml poly dI-dC) and 50 000 c.p.m. labeled probe. After 20 min of incubation at room temperature, 3 ml of 106loading buer was added, and samples were separated on a 6% native polyacrylamide gel for 3 ± 4 h. DNAprotein complexes were visualized by exposing the gels to Kodak ®lm at 7808C. For super shift assays, the nuclear extract was pre-incubated with 5 mg of respective antibody speci®c for each member of the AP-1 family (anti-c-Jun, Jun B, Jun D, c-Fos, Fra-1, all from Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 1 h at room temperature, and then the same steps as described above were followed.
Western-blot analysis
Ten micrograms of the mitochondrial supernatant fraction was separated on a 10% SDS ± PAGE gel to detect the release of cytochrome c from mitochondria. Ponceau staining was used to assess transfer of protein onto the nitrocellulose membrane. The membrane was washed with distilled water to remove excess stain and blocked in Blotto (5% milk, 10 mM Tris-HCl (pH 8.0), 150 mM NaCl and 0.05% Tween 20) for 2 h at room temperature. Membranes were probed with speci®c mouse antibody against cytochrome c (65981A, PharMingen, San Diego, CA, USA). To detect oxidatively modi®ed proteins, the cytosolic fraction was loaded, and the antibodies were used following the protocol provided by Intergen. To detect Jun D, Jun B and c-Jun, 30 mg of the nuclear extract was loaded on a 10% SDS ± PAGE gel. After transferring and blocking, a rabbit polyclonal antibody against Jun D was used (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at a 1 : 1000 dilution. After visualization of protein bands, the membrane was stripped and reprobed with an anti-Jun B or anti-c-Jun antibody (Santa Cruz Biotechnology) at a 1 : 1000 dilution. Before adding the secondary antibody, the membrane was washed twice with TBST (10 mM Tris-HCl with 150 mM NaCl and 0.05% Tween 20), and the membrane was then incubated with horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology) at a 1 : 4000 dilution. The ®nal washing steps included three times (5 min each) with TBST and two times (5 min each) with TBS (10 mM Tris-HCl with 150 mM NaCl). The antibody bands were visualized by the enhanced chemiluminescence detection system (ECL, Amersham Pharmacia Biotech, Piscataway, NJ, USA). For quantitative analysis, the corresponding bands were scanned, and the densities of the positive bands were quantitatively assessed using ImageQuant 5.1 software.
PCR analysis of ornithine decarboxylase (ODC)
Total RNA was isolated from homogenized skin tissue by using TRIzol Reagent (Gibco BRL, Paisley, PA, USA) according to the instructions provided. One microgram of RNA from each sample was used as the starting materials. The relative density of each RT ± PCR product was normalized to the corresponding b-actin level. Oligo(dT) was used to prime RT with the Clontech RT-for-PCR kit. For PCR ampli®cation of cDNA the following primers previously described by Young et al. (1999) were used: ODC (M10624) bp 865 ± 893 and 1252 ± 1225; b-actin (X03765) bp 282 ± 301 and 656 ± 636. PCR was performed at 948C for 5 min followed by 40 cycles of 948C 30 s, 558C 45 s and 728C 45 s. PCR product was separated by agarose gel electrophoresis and visualized by ethidium bromide staining. The PCR product bands were scanned and the densities of the positive bands were quantitatively assessed using ImageQuant 5.1 software.
Statistical analysis
Statistical analysis was performed using one-way ANOVA. Data are reported as means+standard deviation (s.d.).
Abbreviations
The abbreviations used are: 4-HNE, 4-hydroxy-2-nonenal; AP-1, activator protein-1; DMBA, 7,12-dimethylbenz(a)-anthracene; DMSO, dimethylsulfoxide; DTT, dithiothreitol; MnSOD, manganese superoxide dismutase; EMSA, electrophoresis mobility shift assay; JNK, c-Jun terminal kinase; ODC, ornithine decarboxylase; PBS, phosphatebuered saline; PKC, protein kinase C; PMSF, phenylmethylfulfonyl¯uoride; ROS, reactive oxygen species; RT ± PCR, reverse transcription-PCR; TBS, Tris-buered saline; TPA, 12-O-tetradecanoylphorbol-13-acetate.
